Chronic corticotropin-releasing factor type 1 receptor antagonism with antalarmin regulates the dopaminergic system of Fawn-Hooded rats

Medicine and Dentistry

• Antalarmin 100%
• Therapeutic Procedure 62%
• Basal Ganglia 50%
• Striatum 50%
• Corticotropin Releasing Factor 37%
• Receptor 25%
• Alcohol Consumption 25%
• Signaling Mechanism 25%
• Dopamine Agonist 25%
• Drug 25%
• Chemotherapeutic Agent 25%
• Brain 25%
• Messenger RNA 12%
• Dopamine 12%
• Autoradiograph 12%
• Reinforcement 12%
• Dopaminergic System 12%
• Upregulation 12%
• Neuropeptide 12%
• Receptor Antagonist 12%
• Tyrosine 3 Monooxygenase 12%
• Dopamine Transporter 12%
• Medium Spiny Neuron 12%
• Adaptation 12%
• Analysis 12%
• Motivation 12%
• Spine 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Antalarmin 100%
• Corticotropin Releasing Factor 37%
• Fawn Hooded Rat 37%
• Receptor 25%
• Dopamine Receptor Stimulating Agent 25%
• Drug 25%
• Dopamine 12%
• Messenger RNA 12%
• Receptor Antagonist 12%
• Tyrosine 3 Monooxygenase 12%
• Dopamine Transporter 12%
• Neuropeptide 12%

Neuroscience

• Antalarmin 100%
• Corticotropin-Releasing Hormone 37%
• Dopaminergic 37%
• Eicosanoid Receptor 25%
• RNA 12%
• Dopamine 12%
• Receptor Antagonist 12%
• Tyrosine Hydroxylase 12%
• Dopamine Transporter 12%
• Medium Spiny Neuron 12%
• Midbrain 12%
• Emotion 12%
• Behavior (Neuroscience) 12%